Zomedica Corp. (ZOMDF)
0.084
+0.01
(+6.50%)
USD |
OTCM |
Oct 05, 16:00
Zomedica Cash from Operations (Quarterly) : -2.515M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.515M |
| March 31, 2026 | -5.257M |
| December 31, 2025 | -0.6789M |
| September 30, 2025 | -4.704M |
| June 30, 2025 | -5.655M |
| March 31, 2025 | -6.648M |
| December 31, 2024 | -4.094M |
| September 30, 2024 | -4.823M |
| June 30, 2024 | -6.618M |
| March 31, 2024 | -7.59M |
| December 31, 2023 | -4.824M |
| September 30, 2023 | -3.045M |
| June 30, 2023 | -3.704M |
| March 31, 2023 | -4.257M |
| December 31, 2022 | -2.066M |
| September 30, 2022 | -2.632M |
| June 30, 2022 | -4.020M |
| March 31, 2022 | -2.471M |
| December 31, 2021 | -4.865M |
| September 30, 2021 | -4.888M |
| June 30, 2021 | -1.806M |
| March 31, 2021 | -2.638M |
| December 31, 2020 | -2.977M |
| September 30, 2020 | -5.961M |
| June 30, 2020 | -5.605M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.173M |
| December 31, 2019 | -1.844M |
| September 30, 2019 | -2.890M |
| June 30, 2019 | -8.401M |
| March 31, 2019 | -2.581M |
| December 31, 2018 | -3.242M |
| September 30, 2018 | -3.295M |
| June 30, 2018 | -2.696M |
| March 31, 2018 | -1.708M |
| December 31, 2017 | |
| September 30, 2017 | -1.701M |
| June 30, 2017 | -2.083M |
| March 31, 2017 | -1.554M |
| December 31, 2016 | -1.397M |
| September 30, 2016 | -1.648M |
| June 30, 2016 | -0.8687M |
| March 31, 2016 | -0.616M |
| February 29, 2016 | |
| November 30, 2015 | |
| August 31, 2015 | |
| May 31, 2015 | |
| February 28, 2015 | -0.0136M |
| November 30, 2014 | -0.0088M |
| August 31, 2014 | -0.0097M |
| May 31, 2014 | -0.0111M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Biomerica, Inc. | -0.912M |
| Univec, Inc. | -0.0157M |
| Lantheus Holdings, Inc. | 92.20M |
| IDEXX Laboratories, Inc. | 347.16M |
| Neogen Corp. | 30.20M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.3581M |
| Free Cash Flow | -14.80M |
| Free Cash Flow Per Share (Quarterly) | -0.0034 |
| Free Cash Flow to Equity (Quarterly) | -3.144M |
| Free Cash Flow to Firm (Quarterly) | -3.324M |
| Free Cash Flow Yield | -17.98% |